Novo Nordisk and Janus Worldwide: Two Years of Successful Cooperation

In 2018, the representative offices of Janus Worldwide and the Novo Nordisk Pharmaceutical Company in Kazakhstan marked two years of cooperation. During this period, the companies have built an excellent business relationship and become reliable partners.
Janus Worldwide translates Novo Nordisk’s pharmaceutical documentation and marketing materials, and carries out DTP services. Based on their two years of experience working with Janus Worldwide, Novo Nordisk representatives appreciate the high quality of service they receive, as well as the effective communication between the two companies.
“We’ve been working with Janus Worldwide since mid-2016. In the course of our cooperation, Janus Worldwide specialists have proven to be top-notch professionals who always deliver impeccable service. The Medical Translation Department possesses sufficient knowledge to produce quality pharmacological and pharmaceutical documentation translations. Among the main advantages of working with Janus Worldwide are reliability and the wide range services offered,” said Novo Nordisk’s representative in Kazakhstan.
In turn, we, Janus Worldwide, wish to express our gratitude for the trust vested in us by Novo Nordisk’s representative office in Kazakhstan. We are aware of the great responsibility involved in translating medical documentation: the price of errors or ambiguity in this case is very high, so we continue to work on improving the quality of our product and customer service.
The Medical Projects Department at Janus Worldwide employs experts with both linguistic and medical education and extensive experience of working with specialized texts of various types. Our experts have an unquenchable thirst for professional growth in their chosen field, for learning new tools, and for broadening their horizons. We are happy to contribute to the development of the medical industry by providing quality linguistic support to pharmaceutical companies.

About Novo Nordisk

Novo Nordisk is a global pharmaceutical company with a 90-year history of innovation and leadership in the treatment of diabetes and other chronic diseases. Novo Nordisk’s medications are used by more than 28 million diabetes patients* in 180 countries on a daily basis, i.e., one out of every two patients in the world. Novo Nordisk’s headquarters are located in Denmark. Over 41,000 employees work in 77 company offices around the world, and its products are delivered to 165 countries.
For more detailed information, please visit the company’s websites at www.novonordisk.com and www.novonordisk.ru.
* Novo Nordisk Annual Report 2017.

About Janus Worldwide

Janus Worldwide is one of the world’s leading language service providers. The company offers corporate customers 24/7/365 comprehensive linguistic support, including translation, localization, functional and linguistic testing, terminology management, design, and DTP. According to independent research agency Common Sense Advisory, Janus Worldwide was ranked 48th among the Top 100 LSPs in 2018 and 10th among the Top LSPs in Western Europe in 2018. We open new markets and new opportunities for our customers, providing them with the highest quality services that take the linguistic and functional expectations of the target audience into account.
For more information, please visit the company’s website at www.janusww.com.
Press release “Novo Nordisk and Janus Worldwide: Two Years of Successful Cooperation” — is available upon request.